Form 4 for STE Steris
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001628280-24-026578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-04 | 2024-05-31 | STE | Xilas Andrew | SVP, GM, Dental | F - Tax | $222.88 | -124 | 6,347 | -2% | -$27.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-05-31 | F | D | 124 | $222.88 | 6,347 | D | — | — | (F1) 124 shares were withheld from the 426 restricted shares that vested on May 31, 2024. These 124 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 426 ordinary shares were awarded to Mr. Xilas on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. (F2) As of May 31, 2024, 2,486 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. |